A citation-based method for searching scientific literature

Martin Hysek, Johan O Paulsson, Kenbugul Jatta, Ivan Shabo, Adam Stenman, Anders Höög, Catharina Larsson, Jan Zedenius, Carl Christofer Juhlin. Cancers (Basel) 2019
Times Cited: 18







List of co-cited articles
92 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Na Wang, Tiantian Liu, Anastasios Sofiadis, C Christofer Juhlin, Jan Zedenius, Anders Höög, Catharina Larsson, Dawei Xu. Cancer 2014
73
38

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.
Iñigo Landa, Ian Ganly, Timothy A Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A Ghossein, James A Fagin. J Clin Endocrinol Metab 2013
255
38

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
158
38

TERT Promoter Mutation Spatial Heterogeneity in a Metastatic Follicular Thyroid Carcinoma: Implications for Clinical Work-Up.
Adam Stenman, Martin Hysek, Kenbugul Jatta, Robert Bränström, Eva Darai-Ramqvist, Johan O Paulsson, Na Wang, Catharina Larsson, Jan Zedenius, Carl Christofer Juhlin. Endocr Pathol 2019
11
54

TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours.
Johan O Paulsson, Ninni Mu, Ivan Shabo, Na Wang, Jan Zedenius, Catharina Larsson, C Christofer Juhlin. Endocr Relat Cancer 2018
24
33

TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma.
Claire Bournaud, Françoise Descotes, Myriam Decaussin-Petrucci, Julien Berthiller, Christelle de la Fouchardière, Anne-Laure Giraudet, Mireille Bertholon-Gregoire, Philip Robinson, Jean-Christophe Lifante, Jonathan Lopez,[...]. Eur J Cancer 2019
22
33

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
380
33


2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
27



Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
27

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Rui Batista, Joana Peixoto, Catarina Tavares, Ricardo Celestino, Ana Almeida, Catarina Salgado, Catarina Eloy,[...]. J Clin Endocrinol Metab 2014
300
27

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
27

Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
515
22

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A Knauf, Ronak H Shah, Snjezana Dogan, Julio C Ricarte-Filho, Gnana P Krishnamoorthy, Bin Xu,[...]. J Clin Invest 2016
458
22

TERT promoter mutations in thyroid cancer.
Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2016
177
22

Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation.
Naoki Oishi, Tetsuo Kondo, Aya Ebina, Yukiko Sato, Junko Akaishi, Rumi Hino, Noriko Yamamoto, Kunio Mochizuki, Tadao Nakazawa, Hiroshi Yokomichi,[...]. Mod Pathol 2017
37
22

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
22

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
360
22

GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
Xiaotian Yuan, Ninni Mu, Na Wang, Klas Strååt, Anastasios Sofiadis, Yanxia Guo, Adam Stenman, Kailin Li, Guanghui Cheng, Lu Zhang,[...]. Oncogene 2019
21
22

A PCR-based expression signature of malignancy in follicular thyroid tumors.
Theodoros Foukakis, Arief Gusnanto, Amy Y M Au, Anders Höög, Weng-Onn Lui, Catharina Larsson, Göran Wallin, Jan Zedenius. Endocr Relat Cancer 2007
42
16

Prognostic significance of TERT promoter and BRAF mutations in TIR-4 and TIR-5 thyroid cytology.
Simona Censi, Susi Barollo, Elisabetta Grespan, Sara Watutantrige-Fernando, Jacopo Manso, Maurizio Iacobone, Eric Casal Ide, Francesca Galuppini, Ambrogio Fassina, Loris Bertazza,[...]. Eur J Endocrinol 2019
13
23

TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas.
Aya Tanaka, Michiko Matsuse, Vladimir Saenko, Tomoe Nakao, Kosho Yamanouchi, Chika Sakimura, Hiroshi Yano, Eijun Nishihara, Mitsuyoshi Hirokawa, Keiji Suzuki,[...]. Thyroid 2019
16
18

Single-cell imaging reveals unexpected heterogeneity of telomerase reverse transcriptase expression across human cancer cell lines.
Teisha J Rowland, Gabrijela Dumbović, Evan P Hass, John L Rinn, Thomas R Cech. Proc Natl Acad Sci U S A 2019
12
25

TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routine.
Martin Hysek, Johan O Paulsson, Na Wang, Kenbugul Jatta, Claes Lindh, Nelson Fuentes-Martinez, Ivan Shabo, Jan Zedenius, C Christofer Juhlin. Virchows Arch 2018
12
25

Comprehensive Genetic Analysis of Follicular Thyroid Carcinoma Predicts Prognosis Independent of Histology.
Norman G Nicolson, Timothy D Murtha, Weilai Dong, Johan O Paulsson, Jungmin Choi, Andrea L Barbieri, Taylor C Brown, John W Kunstman, Catharina Larsson, Manju L Prasad,[...]. J Clin Endocrinol Metab 2018
31
16


GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
Yanxia Guo, Xiaotian Yuan, Kailin Li, Mingkai Dai, Lu Zhang, Yujiao Wu, Chao Sun, Yuan Chen, Guanghui Cheng, Cheng Liu,[...]. Cell Death Differ 2020
13
23

Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Josh Lewis Stern, Dan Theodorescu, Bert Vogelstein, Nickolas Papadopoulos, Thomas R Cech. Genes Dev 2015
99
16

Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Robert J A Bell, H Tomas Rube, Alex Kreig, Andrew Mancini, Shaun D Fouse, Raman P Nagarajan, Serah Choi, Chibo Hong, Daniel He, Melike Pekmezci,[...]. Science 2015
289
16

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
79
16


TERT Promoter Mutation Predicts Radioiodine-Refractory Character in Distant Metastatic Differentiated Thyroid Cancer.
Xue Yang, Jiao Li, Xiaoyi Li, Zhiyong Liang, Wen Gao, Jun Liang, Shujun Cheng, Yansong Lin. J Nucl Med 2017
43
16

TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma.
Johan O Paulsson, Anton Olander, Felix Haglund, Jan Zedenius, C Christofer Juhlin. Endocr Pathol 2018
8
37



Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy.
M Decaussin-Petrucci, F Descotes, L Depaepe, V Lapras, M-L Denier, F Borson-Chazot, J-C Lifante, J Lopez. Cytopathology 2017
33
16


Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.
C Durante, N Haddy, E Baudin, S Leboulleux, D Hartl, J P Travagli, B Caillou, M Ricard, J D Lumbroso, F De Vathaire,[...]. J Clin Endocrinol Metab 2006
834
11

The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.
Mahul B Amin, Frederick L Greene, Stephen B Edge, Carolyn C Compton, Jeffrey E Gershenwald, Robert K Brookland, Laura Meyer, Donna M Gress, David R Byrd, David P Winchester. CA Cancer J Clin 2017
11

Distant and lymph node metastases of thyroid nodules with no pathological evidence of malignancy: a limitation of pathological examination.
Yasuhiro Ito, Tomonori Yabuta, Mitsuyoshi Hirokawa, Mitsuhiro Fukushima, Hiroyuki Inoue, Takashi Uruno, Minoru Kihara, Takuya Higashiyama, Yuuki Takamura, Akihiro Miya,[...]. Endocr J 2008
20
11

Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
M Schlumberger, C Challeton, F De Vathaire, J P Travagli, P Gardet, J D Lumbroso, C Francese, F Fontaine, M Ricard, C Parmentier. J Nucl Med 1996
341
11

Late bone metastasis from an encapsulated follicular carcinoma of the thyroid without capsular and vascular invasion.
Y Mizukami, A Nonomura, Y Hayashi, K Ohmura, T Michigishi, M Noguchi, S Nakamura, T Ishizaki. Pathol Int 1996
20
11

TERT promoter mutations: a genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation.
Paula Boaventura, Rui Batista, Ana Pestana, Marta Reis, Adélia Mendes, Catarina Eloy, Manuel Sobrinho-Simões, Paula Soares. Eur J Endocrinol 2017
8
25

Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma.
Seung-Hyun Jung, Min Sung Kim, Chan Kwon Jung, Hyun-Chun Park, So Youn Kim, Jieying Liu, Ja-Seong Bae, Sung Hak Lee, Tae-Min Kim, Sug Hyung Lee,[...]. Oncotarget 2016
52
11

In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF V600E mutation.
Almira Nasirden, Tsuyoshi Saito, Yuki Fukumura, Kieko Hara, Keisuke Akaike, Aiko Kurisaki-Arakawa, Miki Asahina, Atsushi Yamashita, Ran Tomomasa, Takuo Hayashi,[...]. Virchows Arch 2016
26
11

Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms.
M Saji, S Xydas, W H Westra, C K Liang, D P Clark, R Udelsman, C B Umbricht, S Sukumar, M A Zeiger. Clin Cancer Res 1999
85
11

Genetic and epigenetic modulation of telomerase activity in development and disease.
Liang Liu, Serene Lai, Lucy G Andrews, Trygve O Tollefsbol. Gene 2004
94
11

Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer.
Federica Panebianco, Alyaksandr V Nikitski, Marina N Nikiforova, Yuri E Nikiforov. Cancer Med 2019
16
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.